PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.48%
Net income growth at 50-75% of ZETA's 11.56%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
13.90%
D&A growth well above ZETA's 8.52%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
61.36%
Some yoy growth while ZETA is negative at -14100.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
3.02%
SBC growth well above ZETA's 1.73%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-33.81%
Negative yoy working capital usage while ZETA is 162.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-4102.07%
Both yoy AR lines negative, with ZETA at -1056.06%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-17.93%
Negative yoy inventory while ZETA is 386.80%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
94.12%
A yoy AP increase while ZETA is negative at -10.42%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
538.20%
Growth well above ZETA's 572.20%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-18.52%
Both negative yoy, with ZETA at -270.87%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
2.39%
Operating cash flow growth below 50% of ZETA's 105.90%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-26.78%
Both yoy lines negative, with ZETA at -0.91%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
93.33%
Acquisition growth of 93.33% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
19.04%
Purchases growth of 19.04% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-49.54%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
8.50%
Growth of 8.50% while ZETA is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-12.07%
Both yoy lines negative, with ZETA at -281.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
13.64%
Issuance growth of 13.64% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-3.56%
We cut yoy buybacks while ZETA is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.